Neurociencia del consumo y dependencia de sustancias psicoactivas
Share Embed Flag
Download ePaper

Neurociencia del consumo y dependencia de sustancias psicoactivas

Neurociencia del consumo y dependencia de sustancias psicoactivas Neurociencia del consumo y dependencia de sustancias psicoactivas

cicad.oas.org
from cicad.oas.org More from this publisher
12.07.2015 Views

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASMarona-Lewicka D y colab. (1996) Reinforcing effects of certain serotoninreleasingamphetamine derivates. Pharmacology, Biochemistry and Behavior,53:99–105.Martin BR y colab. (1976) 3H-delta-9-tetrahydrocannabinol tissue and subcellulardistribution in the central nervous system and tissue distribution in peripheralorgans of tolerant and nontolerant dogs. Journal of Pharmacology andExperimental Therapeutics, 196:128–144.Mascaró BI y colab. (1991) MDMA "extasis": revisión y puesta Al día. [MDMA"Ecstasy": revision and updates]. Revista Española de Drogodependencias, 16:91–101.Mason BJ (2001) Treatment of alcohol-dependent outpatients with acamprosate:a clinical review. Journal of Clinical Psychiatry, 62(Suppl.)20:S42–S48.Matsuda LA y colab. (1990) Structure of a cannabinoid receptor and functionalexpression of the cloned cDNA. Nature, 346:561–564.Mechoulam R y colab. (1995) Identification of an endogenous 2-monoglyceride,present in canine gut, that binds to cannabinoid receptors. BiochemicalPharmacology, 50:83–90.Meisch RA (2001) Oral drug self-administration: an overview of laboratory animalstudies. Alcohol, 24:117–128.Miyazawa A y colab. (1999) Nicotinic acetylcholine receptor at 4.6 A resolution:transverse tunnels in the channel wall. Journal of Molecular Biology, 288:765–786.Molina-Holgado F, Lledo A, Guaza C (1997) Anandamide suppresses nitricoxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes.Neuroreport, 8:1929–1933.Montoya AG y colab. (2002) Long-term neuropsychiatric consequences of“Ecstasy” (MDMA): a review. Harvard Review of Psychiatry, 10:212–220.Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychologicaleffects. Psychopharmacology, 152:230–248.Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of aperipheral receptor for cannabinoids. Nature, 365:61–65.Munzar P y colab. (2001) High rates of midazolam self-administration in squirrelmonkeys. Behavioural Pharmacology, 12:257–265.Naruse T, Asami T (1990) Cross-dependence on ethanol and pentobarbital inrats reinforced on diazepam. Archives of International Pharmacodynamic Therapy,304:147–162.Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction.Nature Reviews in Neuroscience, 2:119–128.Newcomer JW y colab. (1999) Ketamine-induced NMDA receptor hypofunctionas a model of memory impairment and psychosis. Neuropsychopharmacology,20:106–118.Nichols DE (1986) Differences between the mechanism of action of MDMA,MBDB, and the classic hallucinogens. Identification of a new therapeutic class:entactogens. Journal of Psychoactive Drugs, 18:305–313.Nutt DJ, Malizia AL (2001) New insights into the role of the GABA(A) benzodiazepinereceptor in psychiatric disorder. British Journal of Psychiatry, 179:390–396.117

NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASO´Brien CP (2001) Drug addiction and drug abuse. En: Goodman andGilman's: The pharmacological basis of therapeutics, 10a. ed. Nueva York, EE.UU.McGraw Hill:621–667.Ong WY, Mackie K (1999) A light and electron microscopic study of the CB1cannabinoid receptor in primate brain. Neuroscience, 92:1177–1191.Panagis G y colab. (2000) Effects of methyllycaconitine (MLA), an alpha-7 nicotinicreceptor antagonist, on nicotine- and cocaine-induced potentiation of brainstimulation reward. Psychopharmacology (Berlín), 149:388–396.Panksepp J (1998) Affective neuroscience: the foundations of human and animalemotions. Nueva York, NY, EE.UU. Oxford University Press.Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics.Clinical Pharmacology, 16:1–18.Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the humanbrain. Progress in Neurobiology, 61:75–111.Perkins KA y colab. (1993) Chronic and acute tolerance to subjective effects ofnicotine. Pharmacology, Biochemistry and Behavior, 45:375–381.Peroutka SJ (1989) "Ecstasy": a human neurotoxin? Archives of GeneralPsychiatry, 46:191.Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors.Pharmacology and Therapeutics, 74:129–180.Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. CurrentMedicinal Chemistry, 6:635–664.Pertwee RG (2001) Cannabinoid receptors and pain. Progress in Neurobiology,63:569–611.Pfefferbaum A y colab. (1998) A controlled study of cortical gray matter andventricular changes in alcoholic men over a 5-year interval. Archives of GeneralPsychiatry, 55:905–912.Phillips AG, Brooke SM, Fibiger HC (1975) Effects of amphetamine isomersand neuroleptics on self-stimulation from the nucleus accumbens and dorsalnoradrenergic bundle. Brain Research, 1:13–22.Pickworth WB, Heishman SJ, Henningfield JE (1995) Relationships betweenEEG and performance during nicotine withdrawal and administration. BrainImaging of Nicotine and Tobacco Smoking. Ann Arbor, MI, NPP Books:1–13.Piomelli D y colab. (1999) Structural determinants for recognition and translocationby the anandamide transporter. Proceedings of the National Academy ofScience of the United States of America, 96:5802–5807.Platt DM, Rowlett JK, Spealman RD (2001) Discriminative stimulus effects ofintravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergicmechanisms. Journal of Pharmacology and Experimental Therapeutics,299:760–767.Pope HG Jr, Gruber AJ, Yurgelun-Todd D (1995) The residual neuropsychologicaleffects of cannabis: the current status of research. Drug and AlcoholDependence, 38:25–34.Reggio PH, Traore H (2000) Conformational requirements for endocannabi-118

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASMarona-Lewicka D y colab. (1996) Reinforcing effects of certain serotoninreleasingamphetamine <strong>de</strong>rivates. Pharmacology, Biochemistry and Behavior,53:99–105.Martin BR y colab. (1976) 3H-<strong><strong>de</strong>l</strong>ta-9-tetrahydrocannabinol tissue and subcellulardistribution in the central nervous system and tissue distribution in peripheralorgans of tolerant and nontolerant dogs. Journal of Pharmacology andExperimental Therapeutics, 196:128–144.Mascaró BI y colab. (1991) MDMA "extasis": revisión y puesta Al día. [MDMA"Ecstasy": revision and updates]. Revista Española <strong>de</strong> Drogo<strong><strong>de</strong>pen<strong>de</strong>ncia</strong>s, 16:91–101.Mason BJ (2001) Treatment of alcohol-<strong>de</strong>pen<strong>de</strong>nt outpatients with acamprosate:a clinical review. Journal of Clinical Psychiatry, 62(Suppl.)20:S42–S48.Matsuda LA y colab. (1990) Structure of a cannabinoid receptor and functionalexpression of the cloned cDNA. Nature, 346:561–564.Mechoulam R y colab. (1995) I<strong>de</strong>ntification of an endogenous 2-monoglyceri<strong>de</strong>,present in canine gut, that binds to cannabinoid receptors. BiochemicalPharmacology, 50:83–90.Meisch RA (2001) Oral drug self-administration: an overview of laboratory animalstudies. Alcohol, 24:117–128.Miyazawa A y colab. (1999) Nicotinic acetylcholine receptor at 4.6 A resolution:transverse tunnels in the channel wall. Journal of Molecular Biology, 288:765–786.Molina-Holgado F, Lledo A, Guaza C (1997) Anandami<strong>de</strong> suppresses nitricoxi<strong>de</strong> and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes.Neuroreport, 8:1929–1933.Montoya AG y colab. (2002) Long-term neuropsychiatric consequences of“Ecstasy” (MDMA): a review. Harvard Review of Psychiatry, 10:212–220.Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychologicaleffects. Psychopharmacology, 152:230–248.Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of aperipheral receptor for cannabinoids. Nature, 365:61–65.Munzar P y colab. (2001) High rates of midazolam self-administration in squirrelmonkeys. Behavioural Pharmacology, 12:257–265.Naruse T, Asami T (1990) Cross-<strong>de</strong>pen<strong>de</strong>nce on ethanol and pentobarbital inrats reinforced on diazepam. Archives of International Pharmacodynamic Therapy,304:147–162.Nestler EJ (2001) Molecular basis of long-term plasticity un<strong>de</strong>rlying addiction.Nature Reviews in Neuroscience, 2:119–128.Newcomer JW y colab. (1999) Ketamine-induced NMDA receptor hypofunctionas a mo<strong><strong>de</strong>l</strong> of memory impairment and psychosis. Neuropsychopharmacology,20:106–118.Nichols DE (1986) Differences between the mechanism of action of MDMA,MBDB, and the classic hallucinogens. I<strong>de</strong>ntification of a new therapeutic class:entactogens. Journal of Psychoactive Drugs, 18:305–313.Nutt DJ, Malizia AL (2001) New insights into the role of the GABA(A) benzodiazepinereceptor in psychiatric disor<strong>de</strong>r. British Journal of Psychiatry, 179:390–396.117

logo

productos

Resources

Compañías

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!